/C O R R E C T I O N -- Alora Pharmaceuticals, LLC/

In the news release, Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month, issued 06-Oct-2026 by Alora Pharmaceuticals, LLC over PR Newswire, we are advised by the company that changes have...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.